Sell Reviva Pharmaceuticals Holdings Inc (RVPH) today, based on long-term indicators on the stock

Reviva Pharmaceuticals Holdings Inc (RVPH) saw an uptrend of 8.89% in the recent trading with $0.97 being its most recent. The current price level -77.33% lower than the highest price of $4.28 marked by the stock while trading over the past 52-weeks, whereas it is 100.04% higher than the lowest price of $0.49 the company dropped to over past 52-weeks. The latest news story on RVPH appeared in (GlobeNewswire) under the title “Reviva to Participate in Upcoming Investor Conferences in May 2025”.

Squeezing the time span to 30 day period shows us the stock is currently trading -16.36% below one month high and is +31.00% above of the lowest during that time. Looking into the simple moving average, Reviva Pharmaceuticals Holdings Inc (RVPH)’s stock stands at a SMA-50 of $0.8490 while that of 5-day is reading $1.0222.

Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and RVPH’s SMA-200 as of now is $1.2783.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.

Reviva Pharmaceuticals Holdings Inc Earnings – What Happened With RVPH

Coming around sales and income figures on RVPH Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.

RVPH – Reviva Pharmaceuticals Holdings Inc Stock Earnings Estimates

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 46.74 million. RVPH does have institutional investors; and they hold 21.16% of the stock.

Reviva Pharmaceuticals Holdings Inc – Insider Activity and Holdings

As on 2024-06-30, WOODLINE PARTNERS LP was the top most holder in Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) with an ownership of 1.59 million shares of the company or 5.2129 of the stake worth $2.04 million. The filing also reveals MILLENNIUM MANAGEMENT LLC as the second largest holder in the company with a control over 4.0631 of the outstanding shares. Its stake is worth $1.59 million for having 1.24 million shares in hand.

Currently, the stock has been recommended as Strong Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.

Technical Analysis of Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) stock

To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Reviva Pharmaceuticals Holdings Inc (RVPH), we notice that the stock’s 20-day average volume is at 515,330 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 678,060 shares. And to end, RVPH’s 100-day average volume is 1,129,547 shares with 100% of the long-term indicators pointing towards Sell for the stock.

The Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.